Atividade in vitro da ceftriaxona frente a enterobactérias resistentes a aminoglicosídeos

Mimica, Igor; Raphaelian, Terezinha A; Mimica, Lycia M. J.
LAES/HAES ; 9(53): 72, jun.-jul. 1988. tab
Artículo en Portugués | LILACS | ID: lil-57787

Documentos relacionados

  1. Combined Effect of Ceftriaxon and Low-Frequency Ultrasound on the Viability of Staphylococcus epidermidis Cells in a Preformed Biofilm.
  2. Spatial, Ecologic, and Clinical Epidemiology of Community-Onset, Ceftriaxone-Resistant Enterobacteriaceae, Cook County, Illinois, USA.
  3. Comparative study of oral microbiota in the experimental long-term opioid exposure, after its withdrawal and the use of complex drug correction.
  4. Cefepime for Ceftriaxone-Resistant Enterobacterales With Chromosomal AmpC ß-Lactamases.
  5. Treatment effects of the combination of ceftriaxone and valproic acid on neuronal and behavioural functions in a rat model of epilepsy.
  6. Ceftriaxone averts neuroinflammation and relieves depressive-like behaviors via GLT-1/TrkB signaling.
  7. Divergent genetic landscapes drive lower levels of AmpC induction and stable de-repression in <i>Serratia marcescens</i> compared to <i>Enterobacter cloacae</i>.
  8. Ceftriaxone-resistant, multidrug-resistant <i>Neisseria gonorrhoeae</i> with a novel mosaic <i>penA-237.001</i> gene, France, June 2022.
  9. The effects of switching from ceftriaxone to cefotaxime on the occurrence of third-generation cephalosporin-resistant Enterobacterales: A stepped-wedge cluster randomized trial.
  10. Short-term use of ceftriaxone sodium leads to intestinal barrier disruption and ultrastructural changes of kidney in SD rats.